The PI3K/AKT/mTOR signaling axis is frequently overactivated in ovarian cancer and plays a key role in promoting cell proliferation, survival and chemoresistance, with PTEN functioning as a key negative regulator of this pathway. This evidence concerns the gene MTOR and ovarian carcinoma.